Medicare Enrolled
Dr. Juma Bharadia, M.D.
Cardiovascular Disease · Torrance, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bharadia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bharadia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bharadia
Dr. Juma Bharadia is a cardiovascular disease specialist in Torrance, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bharadia performed 3,298 Medicare services across 1,745 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bharadia received a total of $9,428 from 68 pharmaceutical and/or device companies across 436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bharadia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 33% volume in CA
$9,428 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,298
Medicare services
Top 33% in CA for cardiovascular disease
1,745
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~174 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,005 | $12 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
970 | $100 | $189 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
235 | $160 | $372 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
178 | $172 | $367 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
121 | $45 | $118 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
103 | $7 | $25 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
100 | $166 | $378 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
100 | $100 | $168 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
71 | $20 | $150 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
71 | $730 | $1,010 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
56 | $114 | $280 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
42 | $74 | $243 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
40 | $394 | $995 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
39 | $54 | $275 |
| Thallium-201 diagnostic injection A radioactive thallium-201 injection used for diagnostic imaging, with dosage measured in millicuries. |
38 | $29 | $332 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
37 | $145 | $275 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
32 | $63 | $151 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
26 | $49 | $450 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
22 | $48 | $160 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $144 | $235 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.1% high complexity
17.6% medium
74.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,428
Total received (2018-2024)
Avg $1,347/year across 7 years
Top 28% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
436
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,428 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,651
2023
$1,875
2022
$1,440
2021
$1,748
2020
$692
2019
$1,106
2018
$917
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
MDD US Operations, LLC
$177
ABBVIE INC.
$168
ACADIA Pharmaceuticals Inc
$151
UCB, Inc.
$131
SK Life Science, Inc.
$116
Merck Sharp & Dohme LLC
$114
MITSUBISHI TANABE PHARMA AMERICA, INC.
$72
Eisai Inc.
$70
Novartis Pharmaceuticals Corporation
$63
Lundbeck LLC
$60
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$58
Lilly USA, LLC
$57
SCPHARMACEUTICALS INC.
$57
JAZZ PHARMACEUTICALS INC.
$38
Abbott Laboratories
$37
E.R. Squibb & Sons, L.L.C.
$36
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Alexion Pharmaceuticals, Inc.
$31
Alnylam Pharmaceuticals Inc.
$31
PFIZER INC.
$24
LivaNova USA, Inc.
$23
Janssen Pharmaceuticals, Inc
$23
Otsuka Pharmaceutical Development & Commercialization, Inc.
$19
Otsuka America Pharmaceutical, Inc.
$15
Kestra Medical Technology Services, Inc.
$14
Top 3 companies account for 30.0% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$972
ACADIA Pharmaceuticals Inc
$701
AbbVie Inc.
$576
Novartis Pharmaceuticals Corporation
$447
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$424
Merck Sharp & Dohme LLC
$371
Lilly USA, LLC
$354
SK Life Science, Inc.
$306
ABBVIE INC.
$290
Amgen Inc.
$285
Abbott Laboratories
$263
Janssen Pharmaceuticals, Inc
$257
Ipsen Biopharmaceuticals, Inc
$245
MDD US Operations, LLC
$231
Takeda Pharmaceuticals U.S.A., Inc.
$224
PFIZER INC.
$218
Lundbeck LLC
$197
Neurelis, Inc.
$172
Avanir Pharmaceuticals, Inc.
$160
EMD Serono, Inc.
$149
Merck Sharp & Dohme Corporation
$137
MITSUBISHI TANABE PHARMA AMERICA, INC.
$134
Eisai Inc.
$121
AstraZeneca Pharmaceuticals LP
$116
Bard Peripheral Vascular, Inc.
$109
Alexion Pharmaceuticals, Inc.
$102
Boston Scientific Corporation
$101
E.R. Squibb & Sons, L.L.C.
$100
Biogen, Inc.
$96
BIOTRONIK INC.
$95
Medtronic Vascular, Inc.
$93
Alnylam Pharmaceuticals Inc.
$88
Kyowa Kirin, Inc.
$79
Boehringer Ingelheim Pharmaceuticals, Inc.
$79
CSL Behring
$74
JAZZ PHARMACEUTICALS INC.
$74
Sunovion Pharmaceuticals Inc.
$70
Teva Pharmaceuticals USA, Inc.
$68
Neurocrine Biosciences, Inc.
$65
Banner Life Sciences, LLC
$60
SCPHARMACEUTICALS INC.
$57
Regeneron Healthcare Solutions, Inc.
$56
Vertiflex, Inc.
$52
Biohaven Pharmaceuticals, Inc.
$52
Otsuka America Pharmaceutical, Inc.
$38
US WorldMeds, LLC
$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$35
BOSTON SCIENTIFIC CORPORATION
$27
Baxter Healthcare
$26
Adamas Pharmaceuticals, Inc.
$23
LivaNova USA, Inc.
$23
Cook Medical LLC
$22
Invuity, Inc.
$22
Bardy Diagnostics, Inc.
$21
AQUESTIVE THERAPEUTICS, INC.
$21
Biohaven Pharmaceutical Holding Company Ltd.
$21
MEDICOMP INC
$20
Otsuka Pharmaceutical Development & Commercialization, Inc.
$19
Kiniksa Pharmaceuticals, Ltd.
$18
Medtronic, Inc.
$18
GENZYME CORPORATION
$17
ACIST MEDICAL SYSTEMS, INC.
$17
Metacel Pharmaceuticals LLC
$16
Cranial Technologies, Inc
$15
Arrow International, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$14
Kestra Medical Technology Services, Inc.
$14
SANOFI-AVENTIS U.S. LLC
$14
Top 3 companies account for 23.9% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · AMYVID · APOKYN · APTIOM · AUSTEDO · AVONEX · Aimovig · Arcalyst · Assure WCD · Azure · BAFIERTAM · BELSOMRA · BOTOX · BRILINTA · Briviact · CAMZYOS · CAPLYTA · CARDIAC MONITOR · CHANTIX · COMET · CONFIRM RX · COOK MEDICAL WIRE GUIDES · CVI SYSTEMS · Carnation Ambulatory Monitor · Confirm Rx · DAYBUE · DYSPORT · Doc Band · Dysport · ELIQUIS · EMBLEM · EMGALITY · ENTRESTO · Ellipse ICD · FARXIGA · FUROSCIX · Fortify Assura · Fycompa · GAMMAGARD · GENERAL - DBS · GILENYA · GOCOVRI · Gocovri · HeartMate 3 Left Ventricular Dev · Hillrom - Cardiac Ambulatory Monitor · Hizentra · INGREZZA · INVOKANA · Infinity DBS Pulse Generators · Interventional Products · JARDIANCE · JOT DX · KYNMOBI · LEQVIO · Leqembi · LifeVest · Livalo · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Ozobax · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Photonblade · QULIPTA · RADICAVA · REXULTI · Rebif · Repatha · Resolute · Reveal LINQ · Rystiggo · SOLIRIS · SPINRAZA · STEGLATRO · SYMPAZAN · Soliris · Superion · Superion ISS · TRINTELLIX · Trintellix · UBRELVY · ULTOMIRIS · VALTOCO · VENASEAL · VERQUVO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VUMERITY · VYEPTI · Vimpat · WATCHMAN Access System · XARELTO · XYWAV · Xadago · Xience Alpine cornary stent system
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
497
Per 100K population
5.0
County median income
$87,760
Nearest hospital
DEL AMO HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bharadia is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bharadia experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Bharadia performed 1,005 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bharadia receive payments from pharmaceutical companies?
Yes. Dr. Bharadia received a total of $9,428 from 68 companies across 436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bharadia's costs compare to other cardiologists in Torrance?
Dr. Bharadia's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bharadia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Torrance
Browse cardiologists in Torrance ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology